Systemic and topical administration work through different pathways, potentially complementing each other
Based on several studies, it appears that GLP-1 RAs are safe and effective regardless of renal function status
Dermatologic Common (1% to 10%): Hair loss, rash, urticaria Postmarketing reports : Alopecia, angioedema, rash, urticaria Hair loss was reported in up to 5.8% of treated patients vs 1% placebo, with higher incidence associated with greater weight loss (20% or more)
Injection Site Selection and Comfort: A Clinical Framework Semaglutide manufacturers recommend abdomen, thigh, or upper arm as injection sites
So its really meeting that customer where they are on that journey because we know that journey is like this
The problem is keeping athletes consistent